Recombinant Xenopus laevis Reticulon-3-B (rtn3-b)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Xenopus laevis Reticulon-3-B (rtn3-b)

Recombinant Xenopus laevis Reticulon-3-B (rtn3-b) is a protein derived from the African clawed frog, Xenopus laevis. This protein belongs to the reticulon family, which plays a crucial role in the morphogenesis and maintenance of the endoplasmic reticulum (ER) in eukaryotic cells. The recombinant form of Reticulon-3-B is expressed in Escherichia coli and is often used in research to study ER dynamics and related cellular processes.

Characteristics of Recombinant Xenopus laevis Reticulon-3-B (rtn3-b)

  • Expression and Structure: The recombinant full-length Xenopus laevis Reticulon-3-B protein consists of 214 amino acids and is fused with an N-terminal His tag for easy purification and identification .

  • Function: Reticulons are involved in shaping the ER by forming tubules and cisternae, which are essential for protein synthesis, lipid metabolism, and calcium storage. They also interact with other proteins to regulate vesicle trafficking and apoptosis .

Role in ER Morphogenesis

Reticulons, including Reticulon-3-B, contribute to the formation and maintenance of the ER network. They help in creating the tubular structure of the ER by interacting with microtubules and other ER-shaping proteins. This process is crucial for maintaining cellular homeostasis and ensuring proper protein synthesis and transport .

Interaction with Other Proteins

Reticulons interact with various proteins involved in vesicle formation and fusion, such as SNAREs and SNAPs. These interactions are vital for intracellular trafficking and the regulation of ER dynamics .

Potential in Neurodegenerative Diseases

Reticulons have been implicated in neurodegenerative diseases due to their role in ER morphogenesis and intracellular trafficking. Dysregulation of reticulon function may contribute to the pathogenesis of diseases like Alzheimer's and Parkinson's .

Product Specs

Form
Supplied as a lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The specific tag will be determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
rtn3-b; Reticulon-3-B; RTN3.2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-214
Protein Length
full length protein
Species
Xenopus laevis (African clawed frog)
Target Names
rtn3-b
Target Protein Sequence
MAETSGPQSSHISSSSAGDKGSGCAVRDLLYWRDVKQSGMVFGGTMVLLLSLAAFSIISV ISYLVLSLLSVTISFRVYKSVLQAVQKTEEGHPFKPLLEKDIALSSDSFQKGLSSSLAHV NHALKSIVRLFLVEDLVDSLKLALLMWLMTYIGAVFNGITLLILGVLLAFTTPLVYEKYK VQIDHYVSLVHSQVKSITEKIQAKLPGALKKKSE
Uniprot No.

Target Background

Function
Involved in membrane trafficking within the early secretory pathway.
Database Links

KEGG: xla:447369

UniGene: Xl.63454

Subcellular Location
Endoplasmic reticulum membrane; Multi-pass membrane protein. Golgi apparatus membrane; Multi-pass membrane protein.

Q&A

What is Reticulon-3-B and how does it differ from Reticulon-3-A in Xenopus laevis?

Reticulon-3-B (rtn3-b) is one of two paralogs of Reticulon-3 expressed in Xenopus laevis, also known as RTN3.2 (UniProt ID: Q68EW1). While both rtn3-a and rtn3-b are 214 amino acids in length and share significant sequence homology, they display several key differences. The rtn3-b protein differs from rtn3-a in specific amino acid residues, particularly in positions 9-14 (SSSAGE in rtn3-b vs. SSSVGE in rtn3-a) and positions 78-84 (SLSVTIS in rtn3-b vs. SLLTVTI in rtn3-a) . These differences result in slightly altered secondary structures that may affect their functional properties and interactions with other cellular components. When designing experiments that target specific reticulon isoforms, researchers should consider these sequence variations to ensure specificity in their experimental approaches.

What is the domain organization of Xenopus laevis rtn3-b protein?

Xenopus laevis rtn3-b contains the characteristic reticulon homology domain (RHD) that defines all members of the reticulon family. The full amino acid sequence (MAETSGPQSSHISSSSAGDKGSGCAVRDLLYWRDVKQSGMVFGGTMVLLLSLAAFSIISVISYLVLSLLSVTISFRVYKSVLQAVQKTEEGHPFKPLLEKDIALSSDSFQKGLSSSLAHNHALKSIVRLFLVEDLVDSLKLALLMWLMTYIGAVFNGITLLILGVLLAFTTPLVYEKYKVQIDHYVSLVHSQVKSITEKIQAKLPGALKKKSE) reveals a protein structure with hydrophobic regions consistent with membrane association . The RHD includes two hydrophobic regions that likely form hairpin-like structures within the ER membrane, with both the N and C termini facing the cytoplasm. This topology is critical for the protein's function in shaping ER tubules and maintaining membrane curvature. Understanding this domain organization is essential for designing truncated constructs or fusion proteins for specific experimental applications.

How is rtn3-b typically expressed and purified for research applications?

For research applications, recombinant Xenopus laevis rtn3-b is typically expressed using E. coli expression systems with an N-terminal His-tag for purification purposes . The expression protocol generally involves:

  • Cloning the full-length rtn3-b coding sequence (1-214 amino acids) into a bacterial expression vector with an N-terminal His-tag

  • Transforming the construct into an E. coli strain optimized for protein expression

  • Inducing protein expression under controlled conditions (typically with IPTG)

  • Lysing cells and purifying the protein via nickel affinity chromatography

  • Further purification steps may include ion exchange chromatography or size exclusion chromatography

  • The final product is often lyophilized and stored as a powder

The protein requires proper reconstitution before use, typically in a Tris/PBS-based buffer with 6% trehalose at pH 8.0. For long-term storage, addition of 5-50% glycerol is recommended, with aliquoting to avoid repeated freeze-thaw cycles .

What are the optimal conditions for reconstituting lyophilized rtn3-b protein for functional studies?

The optimal reconstitution protocol for lyophilized rtn3-b involves several critical steps to maintain protein functionality:

  • Brief centrifugation of the vial prior to opening to bring contents to the bottom

  • Reconstitution in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Addition of glycerol to a final concentration of 5-50% (with 50% being commonly used) for long-term storage

  • Aliquoting to avoid repeated freeze-thaw cycles, which can compromise protein integrity

  • Storage of working aliquots at 4°C for up to one week, and long-term storage at -20°C or -80°C

For functional assays, the protein should be diluted in an appropriate buffer system that mimics physiological conditions while maintaining protein stability. The exact buffer composition may need to be optimized depending on the specific experimental application .

How can researchers verify the purity and integrity of recombinant rtn3-b preparations?

Verifying the purity and integrity of recombinant rtn3-b preparations is essential for ensuring reliable experimental results. Multiple complementary methods should be employed:

  • SDS-PAGE analysis: Should show a predominant band at approximately 25 kDa (the expected molecular weight of the full-length protein plus tag), with purity typically exceeding 90%

  • Western blotting: Using anti-His antibodies or specific anti-RTN3 antibodies to confirm identity

  • Mass spectrometry: For precise molecular weight determination and potential post-translational modification analysis

  • Circular dichroism: To verify proper protein folding and secondary structure content

  • Dynamic light scattering: To assess protein homogeneity and detect potential aggregation

Additionally, functional assays specific to reticulon proteins, such as membrane binding assays or interactions with known binding partners, can provide further confirmation of protein integrity .

What is the relationship between rtn3-b and neurodegenerative diseases, particularly Alzheimer's disease?

While most research on RTN3's role in neurodegenerative diseases has focused on mammalian models, the high degree of conservation suggests similar mechanisms may operate in the Xenopus ortholog. RTN3 has been implicated in Alzheimer's disease pathogenesis through several mechanisms:

  • RTN3 accumulates in dystrophic neurites surrounding amyloid plaques, forming structures termed RTN3 immunoreactive dystrophic neurites (RIDNs)

  • High-molecular-weight RTN3 aggregates are observed in brains of AD patients and mouse models expressing mutant APP

  • Transgenic mice overexpressing RTN3 develop RIDNs initially in the hippocampal CA1 region, followed by other hippocampal and cortical regions

  • The presence of these dystrophic neurites correlates with impairments in spatial learning, memory, and synaptic plasticity

  • RTN3 may also modulate BACE1 activity, potentially affecting amyloid-beta production

These findings suggest that inhibiting RTN3 aggregation could represent a therapeutic approach for reducing neuritic dystrophy in Alzheimer's disease . Researchers studying Xenopus rtn3-b may find this model useful for comparative studies of reticulon function in neurodegeneration processes.

How can researchers use rtn3-b to study endoplasmic reticulum morphology?

Xenopus laevis rtn3-b can serve as a valuable tool for studying ER morphology due to the reticulon family's established role in shaping ER tubules. Methodological approaches include:

  • Expressing fluorescently-tagged rtn3-b in cell culture systems or Xenopus embryos to visualize ER tubules

  • Using super-resolution microscopy techniques (STED, STORM, SIM) to analyze detailed ER morphology

  • Employing electron microscopy to examine ultrastructural changes in ER following rtn3-b overexpression or knockdown

  • Comparative analysis with other reticulon family members to dissect specific roles

  • In vitro membrane tubulation assays using purified recombinant rtn3-b to directly assess membrane-shaping properties

The reticulon homology domain in rtn3-b contains hydrophobic regions that insert into the outer leaflet of the ER membrane, inducing and stabilizing membrane curvature. By manipulating rtn3-b levels or introducing mutations, researchers can study the molecular mechanisms underlying ER morphogenesis .

How does Xenopus laevis rtn3-b compare with reticulon-3 proteins from other species?

Xenopus laevis rtn3-b shows significant evolutionary conservation with reticulon-3 proteins from other vertebrate species, particularly in the reticulon homology domain. Comparative analysis reveals:

  • High sequence similarity with Xenopus laevis rtn3-a (its paralog due to the pseudotetraploid nature of X. laevis)

  • Strong conservation of the RHD with mammalian RTN3, particularly in the membrane-associated regions

  • Conservation of key functional residues involved in protein-protein interactions and membrane shaping

  • Divergence primarily in the N-terminal regions, which are thought to mediate species-specific and isoform-specific functions

What proteins are known to interact with rtn3-b, and how can these interactions be studied?

Based on studies of reticulon-3 proteins across species, rtn3-b likely interacts with several key proteins involved in membrane morphology and trafficking:

  • Other reticulon family members, forming homo- and hetero-oligomeric complexes

  • DP1/Yop1p family members, which cooperate with reticulons in ER tubule formation

  • SNARE proteins (syntaxins and VAMPs) involved in vesicle trafficking

  • Rab GTPases and their regulatory proteins, such as TBC1D20

  • Bcl-2 family proteins, suggesting a role in apoptosis regulation

These interactions can be studied using multiple complementary approaches:

TechniqueApplicationAdvantagesLimitations
Co-immunoprecipitationIn vivo protein complexesPreserves native conditionsRequires good antibodies
Yeast two-hybridDirect binary interactionsHigh-throughput capableHigh false positive rate
Proximity labeling (BioID, APEX)Spatial protein neighborsCaptures transient interactionsCannot confirm direct binding
Surface plasmon resonanceBinding kineticsQuantitative binding parametersRequires purified proteins
FRET/BRETIn vivo interactionsReal-time monitoringTechnical complexity

When designing interaction studies, researchers should consider the membrane-associated nature of rtn3-b, which may require specialized approaches for protein extraction and analysis .

How can CRISPR-Cas9 genome editing be used to study rtn3-b function in Xenopus laevis?

CRISPR-Cas9 genome editing offers powerful approaches for studying rtn3-b function in Xenopus laevis:

  • Gene knockout: Designing gRNAs targeting conserved regions of the rtn3-b gene to create loss-of-function models

  • Knock-in approaches: Introducing reporter tags (GFP, mCherry) to monitor endogenous protein localization and dynamics

  • Base editing: Creating specific point mutations to study structure-function relationships

  • Prime editing: Precise introduction of defined mutations or small insertions/deletions

When designing CRISPR experiments in Xenopus laevis, researchers must consider its pseudotetraploid genome, which contains two copies of many genes, including rtn3. Both rtn3-a and rtn3-b may need to be targeted simultaneously for complete functional analysis. The following considerations are important:

  • Design gRNAs that either target both paralogs or are specific to rtn3-b

  • Validate editing efficiency using T7 endonuclease assays or sequencing

  • Screen F0 mosaic animals for phenotypes or generate F1 animals with germline transmission

  • Use appropriate controls, including targeting unrelated genes and rescue experiments

This approach allows for sophisticated manipulation of rtn3-b expression and function in a vertebrate model system .

What methodological approaches can be used to study the role of rtn3-b in ER-associated degradation (ERAD)?

Studying the potential role of rtn3-b in ER-associated degradation requires a multifaceted approach:

  • Proximity labeling: Using BioID or APEX2 fused to rtn3-b to identify neighboring proteins in the ERAD machinery

  • Proteasome inhibition: Treating cells with MG132 or bortezomib to determine if rtn3-b levels are regulated by proteasomal degradation

  • Ubiquitination assays: Immunoprecipitating rtn3-b under denaturing conditions and probing for ubiquitin to assess post-translational modification

  • Pulse-chase experiments: Monitoring the turnover rate of ERAD substrates in cells with modified rtn3-b levels

  • ER stress response analysis: Evaluating UPR markers (BiP, CHOP, XBP1 splicing) in response to rtn3-b overexpression or knockdown

Additionally, researchers can use proteomics approaches to identify changes in the composition of ERAD complexes when rtn3-b levels are altered. Co-localization studies using super-resolution microscopy can also reveal spatial relationships between rtn3-b and known ERAD components .

What are common challenges in working with recombinant rtn3-b and how can they be addressed?

Working with recombinant rtn3-b presents several challenges due to its membrane-associated nature:

  • Protein solubility issues:

    • Challenge: Hydrophobic regions can cause aggregation

    • Solution: Use mild detergents (0.1% DDM or CHAPS) or optimize buffer conditions with higher salt concentrations

  • Protein yield limitations:

    • Challenge: Membrane proteins often express poorly in bacterial systems

    • Solution: Consider alternative expression systems (insect cells, mammalian cells) or optimize codon usage for E. coli

  • Functional assessment difficulties:

    • Challenge: Determining if recombinant protein retains native conformation

    • Solution: Develop activity assays based on known functions (membrane binding, protein interactions)

  • Storage stability concerns:

    • Challenge: Protein may lose activity during storage

    • Solution: Strict adherence to storage recommendations (aliquoting, avoiding freeze-thaw cycles)

  • Specificity in detection:

    • Challenge: Cross-reactivity with related reticulon proteins

    • Solution: Validate antibodies thoroughly, consider epitope-tagged versions

For particularly challenging applications, structural modifications such as removing highly hydrophobic regions or creating fusion proteins with solubility-enhancing partners (SUMO, MBP) may be considered, though these may affect certain functional properties .

How can researchers optimize immunofluorescence protocols to detect endogenous or overexpressed rtn3-b?

Optimizing immunofluorescence protocols for rtn3-b detection requires careful consideration of its membrane localization and potentially low endogenous expression levels:

  • Fixation method optimization:

    • 4% paraformaldehyde (10-15 minutes) preserves most epitopes while maintaining membrane structure

    • For certain antibodies, methanol fixation (-20°C, 10 minutes) may provide better results by removing lipids

  • Permeabilization considerations:

    • Gentle detergents (0.1-0.3% Triton X-100 or 0.1% saponin) are typically effective

    • Duration should be optimized (5-15 minutes) to prevent over-permeabilization

  • Blocking optimization:

    • BSA (3-5%) with normal serum (5-10%) from the secondary antibody host species

    • Include 0.1% Tween-20 to reduce non-specific binding

  • Antibody selection and validation:

    • Verify specificity through western blotting and peptide competition

    • Consider using tagged versions (His, FLAG, GFP) if specific antibodies are unavailable

  • Signal amplification strategies:

    • Tyramide signal amplification for low-abundance targets

    • Consider fluorescent nanobodies for improved signal-to-noise ratio

  • Co-staining optimization:

    • Include ER markers (calnexin, PDI) to confirm localization

    • Sequential rather than simultaneous staining may reduce cross-reactivity

For studies involving overexpressed rtn3-b, a titration of expression levels is recommended to avoid artifacts associated with protein aggregation due to extremely high expression levels .

What are promising future research directions for Xenopus laevis rtn3-b?

Future research on Xenopus laevis rtn3-b holds significant promise in several key areas:

  • Developmental biology applications:

    • Investigating rtn3-b's role in Xenopus embryonic development

    • Studying potential functions in neural tube formation and neurogenesis

  • Comparative neurobiology:

    • Using Xenopus as a model to understand evolutionary conservation of reticulon function

    • Comparative analysis with mammalian systems to identify conserved mechanisms

  • Membrane biology:

    • Detailed structural studies of how rtn3-b shapes and maintains ER tubules

    • Investigation of potential roles in other membrane compartments

  • Disease modeling:

    • Development of Xenopus models to study rtn3-b's role in neurodegeneration

    • Screening for compounds that prevent rtn3-b aggregation

  • Protein interaction networks:

    • Comprehensive mapping of rtn3-b interactome in Xenopus

    • Identification of species-specific interaction partners

These research directions could significantly advance our understanding of fundamental cellular processes while potentially identifying new therapeutic targets for conditions where reticulon function is disrupted .

How does current research on rtn3-b contribute to our understanding of membrane protein dynamics and neurodegenerative disease mechanisms?

Research on rtn3-b contributes to broader scientific understanding in multiple ways:

  • Membrane shaping mechanisms:

    • Studies of rtn3-b provide insights into how proteins can induce and stabilize membrane curvature

    • This knowledge extends to understanding other cellular processes involving membrane remodeling

  • Protein aggregation principles:

    • The propensity of RTN3 to form high-molecular-weight aggregates in neurodegenerative conditions offers a model system for studying protein aggregation mechanisms

    • This may reveal common principles applicable to other aggregation-prone proteins

  • ER structure and function:

    • Understanding rtn3-b's role in ER morphogenesis contributes to our knowledge of how this essential organelle adapts to cellular needs

    • This has implications for understanding ER stress responses in various pathological conditions

  • Evolutionary conservation of cellular machinery:

    • Comparative studies between Xenopus rtn3-b and mammalian RTN3 highlight evolutionarily conserved mechanisms

    • This reinforces the value of diverse model organisms in biomedical research

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.